Navigation Links
Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
Date:6/28/2012

(PRWEB) June 28, 2012

ProImmune's Immune Formulation 200® is able to potentiate Glutathione synthesis via the Pleiotropic Paradox, which utilizes the pleiotropic delivery system of the disulfide bond--L-Cystine--to carry L-Cysteine safely to cells,. Upon contact with epithelial cells, the L-Cystine is decoupled by the substrate specific enzyme thioltransferase, allowing L-Cysteine safely into cells to enter into the Glutathione Synthesis chain.

Dr. Albert Crum, a Harvard-trained scientist and CEO of The ProImmune Company, LLC, Rhinebeck (NY) is the inventor of Patent RE42,645E/RE39,734 and its Immune Formulation 200®. University research using Immune Formulation 200® provided by The ProImmune Company, LLC, has demonstrated that this novel Glutathione precursor’s immune support effects are unexpectedly wide-ranging.

The coupling of a thiol-disulfide compound is another safe physiological carrier system for L-Cysteine, because it holds the high oxidizability of L-Cysteine in abeyance ("on hold") until it is delivered to the intracellular milieu.

Metaphorically speaking, the Glutathione pathway of Immune Formulation 200® activates the immune system like a city power grid station which ignites or electrifies a city's lights. The Dietary Supplement Immune Formulation 200® is a strong support for the immune system in multiple ways.

Immune Formulation 200® works physiologically, both to raise bodily Glutathione levels and to activate Nrf2, while offering an inherently natural sweet taste without carbohydrates. Immune Formulation 200® (“F1”), a dietary supplement, is the patented precursor for the intracellular synthesis of Glutathione.

Specifically, research on Immune Formulation 200® provided by The ProImmune Company, L.L.C., has been conducted over several years by a team at Drew University of Medicine & Science, Los Angeles (CA). Other universities such as UCLA, University of California (Irvine), Los Angeles Biomedical Research Institute (Torrance CA), and University of Texas Southwestern (Dallas) are included among those conducting the basic research on Immune Formulation 200®. Research results began being published in 2008. Research studies of Immune Formulation 200® have pointed to the interrelationship between Glutathione repletion and activation of gene Nrf2.

Immune Formulation 200® is winning international consumer favor--for the value of its diversified immunological support and for its naturally sweet taste.

The study which associated Immune Formulation 200® with the activation of Nrf2 was supported by NIH-NCCR Accelerating Excellence in Translation Science Grant (U54 RR026138) and NIH-NIMHDP20MD00182.

© 2012 The ProImmune Company LLC

Read the full story at http://www.prweb.com/releases/2012/6/prweb9653539.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
2. Study improves understanding of surface molecules in controlling size of gold nanoparticles
3. Nanoparticles found in moon glass bubbles explain weird lunar soil behavior
4. Nanoparticles seen as artificial atoms
5. Exotic particles, chilled and trapped, form giant matter wave
6. A milestone in nanoparticle research: Nanoparticle test handbook sets the standards
7. Genesis Biopharma Mentioned Favorably in BioMedReports Article
8. Light touch keeps a grip on delicate nanoparticles
9. New technique uses electrons to map nanoparticle atomic structures
10. New measuring techniques can improve efficiency, safety of nanoparticles
11. Metal nanoparticles shine with customizable color
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
(Date:12/2/2016)... ... 02, 2016 , ... In anticipation of AxioMed’s exclusive cleanroom ... company President, Jake Lubinski will be traveling to Switzerland from December 5-10. Mr. ... Lucerne, and Zurich to discuss the benefits of a viscoelastic disc. AxioMed received ...
(Date:12/2/2016)... ANGELES , Dec. 2, 2016 CytRx ... and development company specializing in oncology, today announced the ... noted sarcoma surgeon, industry consultant, and private healthcare investor, ... is a healthcare leader with clinical and strategic experience ... , CytRx,s Chairman and CEO. "As one of the ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... for North American hospitals, will present its chain-of-custody solution for tracking and securing ... Las Vegas, Nev., Dec. 4-8, 2016. , Aerocom has a proven solution for ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... Nanowear on their recent FDA Class II 510(k) clearance for their flagship medical ... in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. While other ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/24/2016)... Calif. , Nov. 23, 2016 Cercacor ... endurance athletes and their trainers non-invasively measure ... Index, Pulse Rate, and Respiration Rate in approximately 30 ... enables users easy and immediate access to key data ... part of a training regimen. Hemoglobin ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
Breaking Biology News(10 mins):